Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $579,434 (100.0% shares, 0.0% debt)

Holdings (35)

APLS APELLIS PHARMACEUTICALS INC 29.5%
Value ($000) $170,959 Shares 2,503,059 Est. Cost $46.73 Unrealized +26.6%
RCUS ARCUS BIOSCIENCES INC 12.0%
Value ($000) $69,803 Shares 2,668,316 Est. Cost $33.27 Unrealized -20.5%
CHINOOK THERAPEUTICS INC 8.7%
Value ($000) $50,166 Shares 2,551,703 Est. Cost $16.88 Unrealized
HORIZON THERAPEUTICS PUB L 6.7%
Value ($000) $38,650 Shares 624,500 Est. Cost $75.41 Unrealized
GOSS GOSSAMER BIO INC 4.2%
Value ($000) $24,504 Shares 2,045,442 Est. Cost $9.60 Unrealized +29.3%
TNDM TANDEM DIABETES CARE INC 3.9%
Value ($000) $22,725 Shares 474,929 Est. Cost $54.82 Unrealized 0.0%
CLDX CELLDEX THERAPEUTICS INC NEW 3.7%
Value ($000) $21,403 Shares 761,398 Est. Cost $25.60 Unrealized +19.8%
XBI SPDR SER TR 3.3%
Value ($000) $19,306 Shares 243,400 Est. Cost $77.85 Unrealized
MIRATI THERAPEUTICS INC 2.7%
Value ($000) $15,435 Shares 221,000 Est. Cost $69.84 Unrealized
VERONA PHARMA PLC 2.3%
Value ($000) $13,540 Shares 1,324,868 Est. Cost $10.22 Unrealized
VERA VERA THERAPEUTICS INC 2.0%
Value ($000) $11,364 Shares 533,264 Est. Cost $15.54 Unrealized +20.5%
HRMY HARMONY BIOSCIENCES HLDGS IN 1.9%
Value ($000) $10,785 Shares 243,500 Est. Cost $48.78 Unrealized 0.0%
INTRA-CELLULAR THERAPIES INC 1.8%
Value ($000) $10,281 Shares 220,953 Est. Cost $46.53 Unrealized
STOK STOKE THERAPEUTICS INC 1.7%
Value ($000) $9,803 Shares 763,456 Est. Cost $27.91 Unrealized -42.9%
BBIO BRIDGEBIO PHARMA INC 1.6%
Value ($000) $9,281 Shares 933,743 Est. Cost $38.67 Unrealized -73.1%
ALPINE IMMUNE SCIENCES INC 1.5%
Value ($000) $8,820 Shares 1,225,000 Est. Cost $7.20 Unrealized
ASND ASCENDIS PHARMA A/S 1.5%
Value ($000) $8,622 Shares 83,500 Est. Cost $103.26 Unrealized
KARUNA THERAPEUTICS INC 1.3%
Value ($000) $7,760 Shares 34,500 Est. Cost $224.93 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 1.3%
Value ($000) $7,466 Shares 37,300 Est. Cost $190.74 Unrealized 0.0%
FATE FATE THERAPEUTICS INC 1.3%
Value ($000) $7,420 Shares 331,096 Est. Cost $28.89 Unrealized 0.0%
XLO XILIO THERAPEUTICS INC 1.2%
Value ($000) $7,057 Shares 2,425,000 Est. Cost $2.77 Unrealized 0.0%
RNAM AVIDITY BIOSCIENCES INC 1.1%
Value ($000) $6,199 Shares 379,629 Est. Cost $27.48 Unrealized -30.4%
FDMT 4D MOLECULAR THERAPEUTICS IN 0.7%
Value ($000) $4,020 Shares 499,996 Est. Cost $30.23 Unrealized -70.0%
NUVL NUVALENT INC 0.7%
Value ($000) $3,888 Shares 200,000 Est. Cost $16.74 Unrealized 0.0%
JOUNCE THERAPEUTICS INC 0.6%
Value ($000) $3,276 Shares 1,400,000 Est. Cost $2.34 Unrealized
IMVT IMMUNOVANT INC 0.6%
Value ($000) $3,231 Shares 579,061 Est. Cost $7.02 Unrealized -30.3%
DXCM DEXCOM INC 0.6%
Value ($000) $3,222 Shares 40,000 Est. Cost $84.70 Unrealized 0.0%
AKERO THERAPEUTICS INC 0.4%
Value ($000) $2,554 Shares 75,000 Est. Cost $34.05 Unrealized
IPSC CENTURY THERAPEUTICS INC 0.4%
Value ($000) $2,218 Shares 224,300 Est. Cost $24.92 Unrealized -57.7%
MIRM MIRUM PHARMACEUTICALS INC 0.4%
Value ($000) $2,101 Shares 100,000 Est. Cost $24.08 Unrealized 0.0%
ONC BEIGENE LTD 0.3%
Value ($000) $1,523 Shares 11,300 Est. Cost $134.78 Unrealized
MREO MEREO BIOPHARMA GROUP PLC 0.1%
Value ($000) $861 Shares 1,000,000 Est. Cost $1.12 Unrealized
CONNECT BIOPHARMA HLDGS LTD 0.1%
Value ($000) $581 Shares 450,000 Est. Cost $1.29 Unrealized
BCYC BICYCLE THERAPEUTICS PLC 0.1%
Value ($000) $465 Shares 20,000 Est. Cost $23.25 Unrealized
ADCT ADC THERAPEUTICS SA 0.0%
Value ($000) $145 Shares 30,000 Est. Cost $7.24 Unrealized 0.0%